Skip to content

Insider · CIK 0001771664

Michele Ilene Korfin

director

Files at ORGO (Organogenesis Holdings Inc.). First filing -, latest -.

Michele Ilene Korfin files SEC Form 4 as director at ORGO (Organogenesis Holdings Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Michele Ilene Korfin has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 18, 2026ORGO
Organogenesis Holdings Inc.
AGrant or award
Class A Common Stock
+48,828$0.00$0239,073Feb 20, 2026
Feb 19, 2025ORGO
Organogenesis Holdings Inc.
AGrant or award
Class A Common Stock
+49,575$0.00$0190,245Feb 21, 2025

Questions about Michele Ilene Korfin

Answered from the filings on this page, as of the latest one.

Is Michele Ilene Korfin buying or selling?

Michele Ilene Korfin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Michele Ilene Korfin's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michele Ilene Korfin has 0.

Where does Michele Ilene Korfin file Form 4?

Michele Ilene Korfin has filed Form 4 at ORGO (Organogenesis Holdings Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Michele Ilene Korfin: insider trades and track record | InsiderTell